- Home
- / Beaumont Health
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Beaumont Health financials data including stock price, CreditSafe score, income statement, and acquistions and subsidiaries.
Revenue
$4.7 B
FY, 2018
CreditSafe Score
?
Score changed on Jun 08, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2016 | FY, 2017 | FY, 2018 |
|---|---|---|---|
| Revenue | 4.4B | 4.4B | 4.7B |
| Revenue growth, % | 1.5% | 5.0% | |
| Cost of goods sold | 666.1M | 628.9M | 694.6M |
| Gross profit | 3.7B | 3.8B | 4.0B |
| Gross profit margin, % | 84.8% | 85.8% | 85.1% |
| General and administrative expense | 2.4B | 2.5B | 2.6B |
| Operating expense total | 3.5B | 3.6B | 3.7B |
| Depreciation and amortization | 255.0M | 255.1M | 261.3M |
| Investment income | 95.7M | 183.5M | (64.8M) |
| Interest expense | 48.6M | 45.4M | 54.0M |
| Net Income | 286.7M | 325.5M | 147.1M |
Acquisitions & Subsidiaries
| Company name | Date | Deal size |
|---|---|---|
| Lorem | Dec 23, 2021 | $40.0M |
| Ipsum | Jan 18, 2022 | $30.0M |
| Lorem Ipsum | Feb 18, 2022 | $25.0M |
| Dolor | Oct 21, 2021 | $60.0M |
Premium Content only available in Craft’s Intelligence Portal View acquisitions and subsidiaries by company, date, and deal size. Understanding this data enables better supplier & customer negotiations and helps identify potential opportunities or market risks for your firm. Learn more |